Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 01-2013 | 01-2012 | 01-2011 | 01-2010 | 01-2009 | |
| Sales | 5,190 | 6,160 | 4,480 | 4,480 | 4,820 |
| Cost of Goods | 4,790 | 5,170 | 4,160 | 4,570 | 4,790 |
| Gross Profit | 400 | 980 | 310 | -90 | 30 |
| Operating Expenses | 1,531 | 874 | 1,050 | 1,544 | 1,920 |
| Operating Income | -341 | 286 | -570 | -1,064 | -1,100 |
| Interest Expense | 50 | 60 | 50 | 50 | 60 |
| Other Income | -29 | 4 | -70 | -1,026 | -480 |
| Pre-tax Income | -420 | 230 | -690 | -2,140 | -1,640 |
| Income Tax | -1 | 5 | 2 | 0 | -50 |
| Net Income Continuous | -423 | 232 | -698 | -2,145 | -1,591 |
| Net Income | $-420 | $230 | $-690 | $-2,140 | $-1,590 |
| EPS Basic Total Ops | -0.13 | 0.07 | -0.23 | -0.70 | -0.52 |
| EPS Basic Continuous Ops | -0.13 | 0.07 | -0.23 | -0.70 | -0.52 |
| EPS Diluted Total Ops | -0.13 | 0.07 | -0.23 | -0.70 | -0.52 |
| EPS Diluted Continuous Ops | -0.13 | 0.07 | -0.23 | -0.70 | -0.52 |
| EBITDA(a) | $-171 | $546 | $-260 | $-634 | $-560 |